AbbVie’s $2.1B Acquisition Provides In Vivo Cell Remedy to Its Immunology & Irritation Pipeline
AbbVie wasn’t a part of the primary wave of cell therapies developed for most cancers, however IT is positioning itself to contend within the subsequent one, which is increasing to therapies made by engineering immune cells inside a affected person’s physique and the appliance of those cells to autoimmune illness. The pharmaceutical big is committing […]








